Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02667184 · ClinicalTrials.gov registry record · NA

The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Healthy Human Subjects

A NA study of Food Selection, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT02667184 is a NA study of Food Selection that has completed, run by University of Minnesota. The registered enrollment target is 21 participants, below the 818-participant average among 12 other Food Selection trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02667184, a NA study of Food Selection, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to determine subjective gastrointestinal tolerance response and differences in breath hydrogen response following the consumption of different types of low FODMAP oral nutrition supplements. This randomized, crossover study requires participants to arrive to the lab 12 hours fasted, consume an oral liquid supplement and complete gastrointestinal tolerance questionnaires as well as produce samples for breath hydrogen analysis at various time points over a 4 hour time period.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Low FODMAP Oral Nutrition Supplement

Study Locations (1)

Minnesota

  • University of Minnesota - Saint Paul

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2016-05
Est. Completion 2016-06
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT02667184

The ClinicalTrials.gov registry entry for NCT02667184 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 818-participant average among 12 other Food Selection trials with a reported enrollment target (97% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Food Selection appearing as the primary indexed condition, and to 1 intervention - of which Low FODMAP Oral Nutrition Supplement is the first listed.

NCT02667184 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02667184 about?

NCT02667184 is a clinical study titled "The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Healthy Human Subjects". The goal of this study is to determine subjective gastrointestinal tolerance response and differences in breath hydrogen response following the consumption of different types of low FODMAP oral nutrition supplements. This randomized, crossover study requires participants to arrive to the lab 12 hour...

What is the current status of trial NCT02667184?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2016-05. Estimated completion is 2016-06.

What conditions does trial NCT02667184 study?

This clinical trial studies the following conditions: Food Selection.

What interventions are being tested in trial NCT02667184?

The interventions under investigation include: Low FODMAP Oral Nutrition Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02667184?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02667184 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Food Selection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.